NeuroQuest Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NeuroQuest Ltd - overview
Established
2008
Location
-, -, Israel
Primary Industry
Biotechnology
About
NeuroQuest Ltd is an innovative company focused on enhancing cognitive function and mental well-being through advanced digital solutions and neurotechnology applications. Founded in 2008 in Israel, NeuroQuest Ltd specializes in cognitive enhancement and mental wellness solutions. The company was established by Lior Yankelson and has undergone strategic pivots to refine its offerings since inception. NeuroQuest received financing from SCRA’s Technology Ventures in May 2013, which has supported its growth initiatives.
NeuroQuest specializes in enhancing cognitive functions and mental well-being through a range of innovative digital solutions. Their core offerings include advanced neurotechnology applications aimed at improving brain health, optimizing mental performance, and facilitating personal development. These products target individual consumers and organizations in sectors such as education, healthcare, and corporate wellness, catering to cognitive enhancement, stress management, and mental agility. NeuroQuest actively markets its products in North America, Europe, and select regions in Asia.
NeuroQuest generates revenue through multiple channels, including direct-to-consumer sales and partnerships with educational and health organizations. Transactions typically involve subscription models for ongoing access to their digital platforms, as well as one-time purchases for specific applications. The company offers tiered pricing plans based on user needs and organizational requirements, ensuring clients can choose packages that best fit their demands. Flagship products significantly contribute to their overall financial performance.
NeuroQuest plans to continue expanding its product line with new digital solutions aimed at enhancing cognitive functions and mental health, with launches expected in the coming years. The company is targeting further expansion into Europe and Asia by 2025. The financing received from SCRA’s Technology Ventures will be utilized to accelerate product development and market entry initiatives, positioning NeuroQuest to capitalize on growing demand in these regions.
Current Investors
SCRA's Technology Ventures
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.neuro-quest.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
NeuroQuest Ltd - employee data
NeuroQuest Ltd - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman of the Board | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.